Preferred Label : Perrault syndrome 1;
Symbol : PRLTS1;
CISMeF acronym : PRLTS1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Gonadal dysgenesis, XX type, with deafness; Ovarian dysgenesis with sensorineural deafness;
Description : Perrault syndrome is a sex-influenced disorder characterized by sensorineural deafness
in both males and females and ovarian dysgenesis in females. Some patients also have
neurologic manifestations, including mild mental retardation and cerebellar and peripheral
nervous system involvement (summary by Pierce et al., 2010). Pierce et al. (2010)
noted that clinical heterogeneity of Perrault syndrome has prompted classification
into type I, which is static and without neurologic disease, and type II, which is
with progressive neurologic disease. - Genetic Heterogeneity of Perrault Syndrome
See also PRLTS2 (614926), caused by mutation in the HARS2 gene (600783) on chromosome
5q31; PRLTS3 (614129), caused by mutation in the CLPP gene (601119) on chromosome
19p13; and PRLTS4 (615300), caused by mutation in the LARS2 gene (604544) on chromosome
3p21.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the 17-beta-hydroxysteroid dehydrogenase 4 gene (HSD17B4, 601860.0008);
Laboratory abnormalities : Decreased beta-oxidation of pristanic acid;
Prefixed ID : #233400;
Origin ID : 233400;
UMLS CUI : C4551721;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)